throbber
11
`
`Protein Formulation
`
`and Delivery
`
`Second Edition
`
`Edited by
`
`
`Eugene J. McNally
`
`
`Gala Biotech, a Catalent Pharma Solutions Company
`
`
`Middleton, Wisconsin, USA
`
`Jayne E. Hastedt
`ALZA Corporation
`
`Mountain View, California, USA
`
`informa
`
`healthcare
`
`NewVork loodon
`
`Bausch Health Ireland Exhibit 2010, Page 1 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`lnforma HcahhcolfC USA, Inc.
`
`
`
`52 Vanderbilt Avenue
`
`New York, NY I00l7
`
`0 2008 by Jnfonmi Healthcare USA, Inc.
`
`
`
`
`
`
`lnforma Hcalthcnre is an lnformB business
`
`No 1.1luim to original U.S. Govemmcm works
`
`
`
`
`
`
`
`Printed in the Uni1cd S1a1cs of America on ncid-frce paper
`109816$4321
`
`(Han:kover)
`
`lnlemutional Sttmdard Book Number-JO: 0-8493-7949-0
`
`
`
`
`
`
`rntcnm1ional Standanl Book Number-I 3: 978-0-8493-7949-9 (Hardcover
`)
`
`This book conlains informulion obtained from authentic and highly rrganled sources. Reprinted material is
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`quo1ed with permission. ;ind sources are indicated. A wide varie1y of references ure listed, Reasonable effons
`
`
`
`
`
`
`have been rilHde to puUlir.h reliable data and infnrmutiun. Uut the author and the publisher c:umot ussuull:!
`
`
`
`
`responsibility for the validity of all m:ucriols or ro, the consequence or their use.
`
`No pan of this book mr,y bt rcpnnted, r1�pmduced, transmillcd, or utilized in any form by uny elcc1ronic, �han­
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`lc11I. or other means. now know11 or hc:re.1(ter invented, including photoc0pying. microfilming, ond �co«:ling. or
`
`
`
`in nny inronnminn sto111ge or retricvol sys1em. without wriucn permission from the publishers.
`
`foot pcrnUS)IOO to phOIUl.'OflY or UM! 1m11cri11l Cli.!clNIIIC',tlly rro111 1h11o work. plea� llt'Ct=."ll www,cmp right,
`
`
`
`
`
`
`
`
`
`
`
`c.un (ht1p://www.co1,,vri�hl com/) or 1:onlun lhl', Copyright Cluunmc.-c C.:tnt\'t. Inc. (CCC) 222 R1Nwood
`
`
`
`
`
`
`
`Drl\·t, O;u,vcr1>. MA 01'!.l..1, Q78•7�0-�d00 CCC' J\ :1 noc-(or,prollt 1•rJJimi1.11min lhnl pruvitk·, licc11,r, nod
`
`
`
`
`
`
`
`n:ghl1.i1iu11 IU1 ll vmie1)' ufuwn, Fornrgu111znt1t,n, th;ll h11vc l't'c1111ru11lct.l� 1•hotoi.opy lkt'UM\ by tlioCCC,
`
`
`
`11 scpanite system of p11ymen1 has been arranged.
`
`
`
`
`
`
`TradcmArk
`
`
`
`
`
`only for idcntifica1ion and explanation without in1en110 infringe.
`
`
`
`Nolice: Produc1 or corponlle names ma)' be lradcmarks or regis!ered 1radcmarks. and are 05ed
`
`
`
`
`
`Dala Library or Congress Cataloging-in-Puhlicution
`
`
`
`
`
`
`
`Protein fonnuh11ioo nnd delivery/ edited by Eu.gcneJ. McN11lly, JayneE. Hn.�tcdt. -2nd ed.
`
`
`
`p.: cm.-· (Drugs and the ph11rmaccu1ical sciences; 175)
`
`
`
`Includes bihliogrophical references and index.
`
`
`
`ISBN-13: 978-0-8493-7949-9 (hardcover: alk. paper)
`
`1S8N-10: 0•8493· 7949·0 thardcovcr: alk. p11per)
`
`
`
`
`
`
`
`
`
`Ill, Series: Drugs and 1he pharrnaceu1ica! sciences; v.t75.
`
`
`{DNLM: L Protein Conformation. 2. Drug Delivery Sy�1cms. 3. Drug Design.
`
`
`4. Drug S111bili1y. 5. Proteins--administralion & d0$11_gc. WI Dl-l.8938 v.175 2007
`I QU 55. 9 P9667 20071
`
`I. Protein drugs--Dosagc forms. I. McNally. Eugene J .. 1961-II. Hastedt. Jayne E.
`
`RS431.P75P77 2007
`
`615'. I 9--dc22
`
`Visit the lnfomnt Web site at
`
`www.informa.com
`
`and the lnforma Hetilthcare Web sire at
`www.in(ormahealthcare.com
`
`2007023435
`
`Bausch Health Ireland Exhibit 2010, Page 2 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`2
`
`Chemical Considerations in Protein
`and Peptide Stability
`
`Paul M. Bummer
`y, Lexington, Kentucl<.y, U.S.A.
`University of Kentuck
`
`DEAM I DATION
`
`Introduction
`
`The dcamida1ion reactions of asparagine (Asn) and glulamine (Gin) side-chains
`are among Lhe most widely studied nonenzymnlic covalent modifications lo
`proteins and peptides ( 1 -7). Considerable research efforts have been exlendcd
`to elucidate the detai.ls of the dcamidation reaction in both in vitro and in vivo
`systems. and a nu mber of well-wrillen, i n-depth reviews are available ( 1 -5, 8,9).
`This work_ touches only on some of the highlights of the reaction and on the roles
`played by pH. temperature. buffer, and other formula1ion components. Possible
`dcamidation-associated changes io the protein structure and state of aggregation
`also are examined . The emphasis is on Asn deamidation, since Gin is significantly
`less reactive.
`
`Reaction Mechanism
`
`The primary reaction mechanism for the deamidation of Asn in water-accessible
`regions of peptides and proteins at basic or neutral conditions is shown in Figure I ,
`For the present, discussion i s confined to the intramolecular mechanism, uncom­
`plicated by adjacent amino acids at other points in the primary sequence. Under
`alkaline conditions, the key step in the reaction is the fommtion of n deprotonatcd
`amide nitrogen, which carries out the rate-determining nucleophilic attack on the
`side-chain carbonyl, resulling in a tetrahedral intermediate and finally the formation
`of the five-member succinimide ring. For such a react.ion, the leaving group must be
`
`7
`
`Bausch Health Ireland Exhibit 2010, Page 3 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`8
`
`�J>,-R-,---+
`
`0
`
`Asparaglnyl Residue
`
`Bummer
`,, l� N�
`R1
`0
`
`Reactive r ion
`
`Figure 1 Proposet.l reuclion 111cchanbm for dcamidntion of asparaginyl residue. Note the
`formation of the �uc<:inl1oldyl mtetmcdi:ite and the two possible final products.
`
`Aspartyi Residue
`lsoaspartyl Residue
`
`easily protonaled, and in this-case, it is responsible for the characteristic fonnation of
`
`
`
`
`
`
`
`
`result­hydrolysis, (NH3). The succinilrude ring intermediate is subject to
`ammonia
`
`
`
`
`ing In either the corresponding ospartic acid or the isoaspartic acid ('3--aspartate),
`
`
`
`
`
`
`Often, the ratio of the products is 3: I, isoaspartaie to aspartate (10-12). In the case
`
`
`
`
`
`of acid catalysis (pH < 3), a tetrahedral intermediate is also fom1ed, but breaks down
`
`with the loss of NH3 without
`
`
`
`going through the succinimide ( 13-17). The reaction
`
`
`
`
`
`
`also appears to be sensitive to racemization at the IX-carbon. resulting in mixture1; of
`
`
`
`
`
`
`o- and 1,-isomers ( 10, 13-15). The rate of degradation of the parent peptide in aque­
`
`
`
`ous media often follows pseudo-first-order kinetics (16,17).
`
`Bausch Health Ireland Exhibit 2010, Page 4 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`
`
`
`
`Chemic;i/ Considerations in Protein and Peptide St;ibility
`
`
`
`
`
`9
`A number of other alternative reactions arc possible. The most prevalent
`1•eaction appears to be. 3 nuclcophilir m111ck of the Asn sic1(N!hain amide nitrogen
`on 1hc pt:p1ide carbonyl, rc,ul1lng in mnin-chain cl�avage ( 10, 16, 18). Thisreac­
`uon (Fig. 2) is slower than 1.ha1 of cyclic imide formation and L" mos1 frequemly
`observed when Asn is followed by proline. a residue incapable of forming an ion•
`ized peptide-bond nitrogen.
`Under conditions of s.trong acid (pH l-2), deamidalion by direct hydrolysis of the
`amide side-chain becomes more favorable than formation of cyclic imidc (16, 19).
`Under these extreme conditions, the react.ion is: often complicated by main-chain
`cleavage and denaturation. Deamidation by Lhis mechanism is not likely Lo pro­
`duce isoaspartare or significant racemization (16).
`Under more moderate condjtions, the effect of pH is 1.hc result of two
`opposing reac1ions: (i) deprotonation of the peptide-bond nitrogen, promoting
`
`pH Dependence
`
`+
`
`R1 = Amino end of protein
`Figure 2 Proposed reaction mechanism for rnam-chain cleavage by asparaginyl residues.
`R2: Carboxyl end of protein
`
`Bausch Health Ireland Exhibit 2010, Page 5 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`1 0
`
`Bummer
`
`the reaction and (li) protonation of the side•chain-leaving group, inhibiting the
`reaction. ln deamidation reactions of short chain peptides uncomplicated by
`structural alterations or covalent dimcri1.ation (20), the pH•rate profiles exhibit
`the expected "V" shape, with a mi nimum occurring in the pH range of3 lo 4 ( 1 6).
`Computation studjes by Peters and Trout (2 1 ) have been helpful in shedding light
`on the effect of pH. These authors have suggested that under mildly acidic condi­
`tions (3 < pH, 4), the rate-limiting step is the attack of the dcprotonated nitrogen
`on the side-chain. The rate-li miting step at neutral pH is the hydrogen transfer
`reaction, while under basic conditions (pH > 7), it is the elimination of NH; from
`the tetrahedral iotennediate. Experimental studies have shown that 1·he increase
`in rate on the alkaline side of the minimum docs not .strictly correlate with the
`increase in deprotonation of the amide nitrogen, indicating that the rate of reac­
`tion is not solely dcpendenl on the degree of the peptide..bond ni1rogen deprot­
`onation ( 1 6, 1 9). The pH minimum in the dcamidution reaction measured in vitro
`for proteins may (22) or may not (23) fal l in the same range as that of simple
`peptides. Overall pH-dependent effects may be modified by structure-dependent
`factors, such as dihedral angle flexibility, water accessibil ity, and proximity of
`neighboring amino acid sjdc-chains (see section Peptide and Prmein Structure).
`
`Effect of Temperaiure
`
`The temperature dependence of 1hc dcarnidation rare has been studied in a variety
`of simple peptides in solution ( 1 6,24,25). Small peptides arc easily designed to
`avoid competing react.ionS', such as oxidation and main-chain cleavage, and arc
`thus useful to isolate auentioo directly on the dcamidation rate. In solution, deam­
`idation of small peptides tends lo follow an Arrhenius rclarionship. Activation
`energies of the reaction do tend to show pH dependence, and a discontinu ity in the
`Arrhenius plot is expected when 1he mechanism changes from direct hydrolysis
`(acid pH) to one of cyclic imide (mildly acid.ic to alkaline pH).
`The deamidation rate uf proteins also hows temperature dependence
`(23,26,27) under neutral pH. For deamidation reactions alone, temperature­
`associated rate acceleration in proteins may be due lo enhanced flexibility of the
`molecule, allowing more rapid formation of the cyclic imide (28). or it may occur
`by catalysis by side-chains brought into the v icinity of the deamidation site (5).
`The availability of water appears to be an iir1portant determinant in
`temperature-associated effects. In studies of lyophilized formulation of Val-Tyr­
`Pro-Asn-G1y-Ala, the deamidation rate constant was observed to increase about an
`order of magnitude between 40°C and 70°C (29). In contrast, in the solid state, the
`Arrhenius relationship was not observed. Funher. the deamidation in the solid stale
`showed a marked dependence upon the temperature when 1he peptide was Jyop.hi­
`li1..ed from a solution of pH 8 1 while little temperature dependence was observed
`when lyophilization proceeded from solutions al either pH 3.5 or pH 5. The authors
`related this temperature difference to changes in the reaction mechanism that may
`occur as a function of pH.
`
`Bausch Health Ireland Exhibit 2010, Page 6 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`
`
`
`
`Chemical Considerations in Protein and Peptide Stdbilily
`
`1 1
`
`Adjuvants and Excipients
`
`The influence on deamidation by a variety of buffer ions and solvents has been
`examined. As pointed out by Clelapd et al. (4) and reinforced by Tomizawa et
`al. ( 1 3), many of these additives are unlikely to be employed as pharmaceutj­
`cal excipiems for fonnu laLion, but they may be employed in protein isolation
`and purification procedures (30). I mportant clues to stabilization strategies can
`be gained from these studies, In the follow ing, il is fruitful to keep in mind the
`importance of the attack of the ionized peptide-bond nitrogen on the side-chain
`carbonyl and the hydrolysis of the cyclic imide (Fig. I ),
`
`B u ffers
`
`Buffer catalysis appears to occur in some but not all peptides and proteins studied
`(5). Bicarbonate ( 1 6) and glycine ( 12) buffers appear to accelerate deamidatioo. On
`one hand, the phosphate ion has beeo shown to catalyze deamidation, both in pep­
`tides and in proteins ( 12, 1 3, 16,3 1 -34), generally in the concentration range of O to
`20 mM. Capasso et al. (35,36) observed the acceleration of deamidation by acetate,
`carbonate, Tris, morpholine, and phosphate buffer., only in the neutral to basic pH
`ranges. On the other hand, Lura and Schrich (37) found no influence on the rate of
`deamidation of Yal-Asn-Gly-Ala when buffer components (phosphate, carbonate, or
`imidazole) were varied from O to 50 mM. A general acid-base mechanism by which
`the phosphate ion calalyws deamidalion was challenged in l 995 by Tomizawa et al.
`( 1 3), who found lhat lhe rale of lysozymc at 1 00°C did not exhibit the expected linear
`relationship of deam1dation rate on phosphate concentration. Although not linked to
`deamidation, il is worthwhile to note that at pH � 8 and 70°C, tris(hydroxymethyl)
`ami nomethanc buffer (Tris) has been shown to degrade to liberale highly reaclive
`fom1aldehyde in forced slabilicy studies of peptides (38).
`
`I o n i c Slrength
`
`The effects of ionic strength appear to be complicated and nor open to easy gen­
`eralizations. Buffer and ionic strength effects on deamidation are evident in pro­
`teins at neutral to alkaline pH (5). In selected peptides and proteins, the catalytic
`activity of phosphate has been shown to be reduced moderately in 1he presence
`of salts NaCl. Li Cl, and Tris HC I ( I 2, 1 3 ). Of these sails, NaCl showed the least
`protective effect against dcamidation ( 1 3).
`In the peptide Gly-Arg-Asn-Gly at pH 10, 37 °C, the half-life ,,,, of dcami­
`dation dropped from 60 hours to 20 bou,s when the ionic strength was increased
`from 0.1 lo 1 .2 (22). However, in the case of Val-Ser-Asn-Gly-Va! at pH 8, 60°C,
`there was no observable difference in the 1 112 of deamidation when solutions with­
`out salt were compared to those containing I M NaCl or LiCI ( 1 2). Interestingly,
`for lysozyme at pH 4 and 1 00°C, added salt showed a protective effect against
`deamidation, but only in the presence of the phosphate ion ( 1 3) .
`In reviewing the data above, Brennan and Clarke ( 1 7) tentatively attributed
`the promotion of deam.idation by elevated levels of ions to enhanced stabilization
`
`Bausch Health Ireland Exhibit 2010, Page 7 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`12
`
`Bummer
`
`of the ionized peptide-bond nitrogen, promoting attack on the side-chain amide
`carbonyl. Other mechanism� would include dis11.1p1io11 or rer1 k1ry st mcrurc in pro­
`teins that may have stahillled Asn residues. in some us�yet u nknown fashion. That
`promotion of de:1midation is observed in some cases of peptides. and inhibi1iun in
`others doc� suggest rather complex and competing effects. Clearly, the stabilizing
`effects t when observed at all, are often at levels of sa1t too concentrated for most
`pharmaceutical formulations.
`
`Solvents
`
`The effect of various organic solvents on the rate of dcamidation has not received
`much altention; it would be expected, however, that in the presence of a reduced
`dielectric medium. the pept ide-bond nitrogen would be le» likely to ionize. Si nc.e
`the anionic peptide- bond nitrogen is ncccs�ary in the format ion of t he cyclic
`imide, a low dieicctric medium would retard the progress of 1he reaction and be
`reflected in the free energy difference for ionization of the peptide-bond n itrogen
`( 1 7). Fol lowing this hypothesis, 13rcnnun and Clnrke (3\1) anuly1.cd succini midc
`formation of the reptitle Vnl -Tyr-Prc,-Asn-Gly-Ala I t he ,ame peptide employed
`by Patel ilnd Borchardt ( 16) in studies of pli effects in aqueous solutionJ as n func­
`tion of org;mic cosolvent (ethanol, glycerol, and dioxin} at constant pH and ionic
`strength. The lower dielectric constant media resulted in a significantly lower rate
`of deamid:ition, in agreement with the hyp(llhesis. II was ;,)rgucll lhOI 1 hc �imi lar
`rates of deamidation for different cosoJvenl systems of the same effective die lec­
`tric constant indicated that changes in viscosity and water content or the medium
`did not play a significant role.
`The effect of organic cosolvents on deamidation in proteins is even less
`well characterized than that of peptides. Trifluoroethanol (TFE) inhibits deami­
`dation of lyso,.yme at pli 6 and l 00°C ( 1 3), and of the dipeptide Asn-Gly. but
`does not inhibit Lhe deamidation of free amino acids. The mechanism of protec­
`tion is not c1car; direct interaction of the TFE with the peptide bond was postu­
`l attd, hut nm demomarnted. A n n l !emat ive hyporhesi� i!i t hut TF'E induces �reatt:r
`struct ural rigid ity in 1 hc prolei n , producing a strut·turc somewhat resis1nnt to the
`fonm.ui n of the cyclic imide intcrmcdime� 01her. ph:m11:1ceu1 ical ly ncceptable
`solvents, ethanol and glycerin, did not exhibit the same protective effects as TFE
`on lysozyme.
`Of course. in dosage form design, organic solvents such as TPE are not use­
`ful as pharmaceutical adjuvants. The effects of low dielectric may srill supply a
`rationale for t 11e solubi.Hzntion of peptides in aqueous surfactant systems, where
`the hydrophobic region of a micelle or liposome could potentially enhance the
`stabilization of the Asn residues from deamidation. As pointed out by Brnnmm and
`Clarke ( 17), the results of experiments in organic solvents can have implications on
`the prediction of points of deamjdulion in proteins tlS well. For Asn residues near
`the surface of the protein, where the dielectric constant is expected to approach th:tl
`of water, the deumidntion rate would be expected to be high. For Asn residues bur­
`ied in more hydrophobic regions of the protein. where polarities are thought to be
`
`Bausch Health Ireland Exhibit 2010, Page 8 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`...--
`
`Chemicdl Considerations ;n Protein and Peptide Stability
`
`13
`
`to be coosidcrnbl y slower:
`
`more in line with that of ethanol or dio.xane (40), reaction rates would be expected
`
`Compututional �1udie!'I un the cffec1� uf solvent on !ht: reaetion were carried
`out recently by Cata� c1 al.. (41 ). 11,ey rcp1.1r1 rhat, in the absence of waler, 1J1e
`overall activation ei1�rl:l'.y barrier is on 1he ordcr of50 kcal/11101, �nd thlit this drop�
`to a value of about 30 kcal/mo) in the presence of water. fn all, about three water
`molecules participate directly in the reaction, assisting in hydrogen transfer and in
`the cyclization outlined in Figure I •
`
`
`Polymers and Sugars
`Considerable in1erest has developed in the stabilization ofproteirtS and peptides in
`solid matrices, either polymeric or sugar based. Jn mosl solid polymer matrices.
`the primnry role is to improve phammcokinellc anti pharmcodynamic properties
`of the nclive by modifying release clmr.ictcrislics nnd most studies arc designed
`
`lization of proteins, with the intent of maintaining the tertiary structure and pre­
`
`The state of the polymer and the activity of water appear to be critical factors
`in the stabilization of the peptide against deamidation. In general, the observed
`
`Peptide- stabili1y in polymer sn0:1riccs 1ha1 :ue 1hemseh1c-s also undergoing
`dcgrodation provide� a unique chnllenge. For exafnple. i1 has been observed that
`PVP rnay form adtl11c1� with 1lw N-terminu, or peplides (48). Sysremnlic sludics of
`
`with this intention in mind (42). Sugars are usually employed as un aid to lyophi­
`venting aggregation (43).
`degmdution rote constants exhibit the following mnk order: solution> rubbery
`polymer> glassy polymer (38.44-46). �lowever. this observation docs not appeur
`to be valid in every case (44). It has been proposed that up to 30% of a peptide
`may bind to polyvioylpyrrolidone (PVP) in the solution state, complicating the
`kinetic analysis (47).
`the deaniidution of a model peptide in films of the copolymer polylactic-glycolic
`acid (PLGA) have ,hown that the rcuclion is the primary roule of degradation
`only Qfter longer storngc limes at higher water content (49). The delay in the
`onset of deamidution of peptide in PLGA may be relttted to the time necessary to
`establish an "acidic microclimate" that arises from the hydrolysis of the polymer
`(50). In support of this acid-catalyzed deamidation hypothesis in PLGA films, the
`tions of the mobility of peptide, water, NHi, and polymer in PVP matrix have
`been carried out by Xiang and Anderson (51). They observed that the diffusiv­
`dynamics of the peptide in the glassy polymer exhibited a higher energy barrier
`cyclic intermediate in the glassy polymer and the diffusion away of the NH, after
`
`reaction product. isonsportutc was not foundA
`Computational i.ludies may 1'Upply udditional insight. Computer simula•
`
`ity of water, NH3, and peptide were between two and three orders of mugnilude
`slower in PVP compared to aqueous solu1ion. Importantly, the confonnmional
`
`between states than seen for the peptide in wmcr. Thus, two of the cri1jcal events
`in the process of deamidation, the conformational chnnges necessary to form the
`
`release, are both slowed considerably in the solid state ..
`
`Bausch Health Ireland Exhibit 2010, Page 9 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`1 4
`
`Bummer
`
`The effect of sugars on the deamidation of a model peptide has been exam­
`ined. At pH = 7, a solution of peptide in a 5% sucrose or mannitol reduced the
`deamidation rate to about 16% of that found in the absence of sugars (52). When
`stored in the solid state. the rate of reaction was even slower, although sucrose
`appeared to stabilize the peptide to n gr1''11er extent t han did mnnnitol. lt was
`observed that sucrose remained amorphous during the lest perio(I wl1ile mannitol
`crystal lized, complicating the interpretatil)n or the daw (53). Cleland et al. (43)
`determined that 360: I was the optimal sugar-antibody molar ratio necessary to
`inhibit aggregation and deamidation over a th1·ee-n'lonth period. Sugars sucrose,
`trehalose, and mannitol were able to stabil ize the protein so long as Jess than 8.4%
`moisture was present.
`Our understanding of the stabilization of peptides and proteins in polymer
`and sugar matrices is far from complete, and additional insight lnto the molecular
`mechanism rnigh1 benefil frnm the bounty of stud ies cutTied out with small mol­
`ecules in similnr sy ·terns. Ex periments must be de$igncd carefully and interpreted
`with caution so as ro clearly separate the solvent effects of water and perhaps even
`N H3 on the reaction from the plastisizing effects on the matrix.
`
`Peptide and Protein Structure
`
`The abi lity to identify whi h Asn or Gin residues i n u thempeutic protein r
`pept ide may be vulnerable 10 dcamidm ion would have grem pract icnl ltpi)l ic:,­
`tlon in preformuJntion and formulution .studies. 111c effects nr various level� or
`1ruc1ure-pri mary1 secondary, and 1cr1 iary-are believed 10 be complex n11d
`varied. Al prese111, only primary structure effect� hnvc been charat·terizcd i n u
`systematic manner.
`
`Primary Sequence
`
`The primary sequence of amino acids i n a peptide or protein is often tbe tirs1
`piece of structural data presented to the formulation scientist. Considerable effort
`has been spent to elucidate the influence of Hanking amino acids on the rates of
`dea.mida.tion or Asn and Gin residues. The potential effects of flanking amino
`ac ids are best elucidated in simple peptides, uncomplicated by side reactions or
`secondary and teniary structure effects.
`
`In an extended series of
`Effect of amino acids preceding Asn or Gin:
`early studies, Robinson and Rudd (24) examined the innucncc of primary sequence
`on the dearnidation of Asn or Gin in the middle of a variety of pentapeptides. Mild
`physiologic conditions (pH 7.5 phosphate buffer at 37°C) were employed. A few
`general rules can be extracted from this work:
`
`I.
`
`In practically every combination tested, Gin residues were less prone
`to deamidation than Asn. For the two residues placed in the middle of
`otherwise identical host peptides, the half-life of the reactions di ffered
`hy a factor rnnging from two- to threefold.
`
`Bausch Health Ireland Exhibit 2010, Page 10 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`15
`
`Chemical Com;derdtions in Protein omd Peptide SlabUity
`
`2. ln peptides Gly-X-Asn-Ala-GJy, steric hindrance by unjonizcd X side­
`chains inhibits dcamidarioo. The rank order of deamidation rale found
`wa, Gly >Ala> Val> Leu> lie, with the tin ranging from 87 to 507
`days. It remains unclear why bulky residues inhibit the reaction, but
`reduced flexibility of the sequence may be a fact0r. A similar effect was
`noted when Gln replaced Asn. ln this case, t112 ranged from 418 to 3278
`days, in accordance with the di_mjnished reactivity of Gin.
`3. Forlhe same host peptide, when the X side-chain was charged, the deam­
`idation rate of Asn followed the rank order of Asp> Glu > Lys > Arg.
`Effect or amino acids followingAsn or Gin: Early experiments on dipep­
`tide.c. under extreme conditions indicated a particular vulnerability of the Asn-Gly
`sequence to deamidation (54). More recent studies of adrenocorticotropic hor­
`mone (ACTH)-like sequence hexapeptide Val-Tyr-Pro-Asn-Gly-Ala under physi­
`ologic conditions (55) have vetified thnt deamidation is extremely rapid (t,n of 1.4
`days at 37°C). The formation of the succinimide intennediate is thought to be the
`basis for the sequence dependence ( I 0) of deamidation. It is genera Uy believed
`that bulky residues following Asn may inhibit sterically the formation of the suc­
`cinimidc ini.ermediare iu 1..he dearu.idation react.ion.
`Stcric hindrance of the cyclic imide formation is not tbe onJy possible
`gcne-s.is of sequence-dependent deamidation. The resistance to cyclic imlde
`formation in the presence of a carboxyl-H:1.nking praline peptide may be related
`to the inability of the prolyl amide nitrogen to attack the Asn side-chain (10).
`The computational studies of Radkiewicz et al. (56) suggest that the effect of
`the adjacent residue may largely be allributed lo electroslalic/inductive effects
`intluencing the ability of the peptide nitrogen atom 10 ionize (as seen in Fig. I).
`In the case of glycine, the inductive effect is insufficient to explain the resuJts,
`and the authors argue that the ability of glycine to sample more conformational
`space compared to other amino acids may help stabilize the nitrogen anion.
`Experimentally, the replacement of the glycyl residue with the more bulky
`leucyl or prolyl residues resulted in a 33-to 50-fold (respectively) decrease in
`the rate of deamidation (10). Owing to the highly flexible nature of the di pep­
`tide, th_e deamidation rate observed in Asn-Gly is thought to represent a lower
`limit. In mane recent studies. deamidation of Val-Tyr-X-Asn-Y-Ala. a peptide
`sequence derived from ACTH, was examined with different residues in both
`flanking positions (57). When X was histidine (and Y is glycine), no acceleration
`of deamidation was found relative to a peptide where X is proline. Placing a His
`following theAsn was found to re...,ult in similar rates of deamidation when X was
`phenylalanine, leucine, or valine. The rate when X was histidine was slower lhan
`that of alanine, cysteine, serine, or glycine. These results indicate that histidine
`does not have unique properties in facilitating succinimide formation. Of inter­
`est was the observation that histidine on the carboxyl side of the Asn did seem lo
`accelerate main-chain cleavage producl"·
`
`Bausch Health Ireland Exhibit 2010, Page 11 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`16
`
`Some of the general rules for peptides may also show higher levels of
`dependence on primary sequence. Tyler-Cross :ind Schrich ( 12) smdied the influ­
`ence of diffcrcm amino acids on 1he udjncem amino end of the pcnrnpcptide Val­
`X-Asn-Ser-Val at pH 7.3. For X; His, Ser, Ala, Arg, and Leu, dcamidmion rates
`were essenLially constant and approximately seven times slower than the Val•
`Ser-Asn-Gly-Val standard peptide. Of special interest to the investigators was the
`observation of no djfference in deamidation rates between those amino acids with
`and withnm �-branching (such as vo..line ror glycine). This is ill di reel contrast 10
`the findings of Robinson and Rudd (24) of 10-fold differences lu deamidat,on
`for valine substitution for glycine in Gly-X-Asn-Ala-Gly, shown earlier. Under
`the mild alkaline conditions of Patel nod Borchardt (16), Val-,Yr-X-Asn-Y-Alu,
`no difference in the deamidation rate constants was observed when proline was
`substituted for glycine in the X position.
`Data mining: Data-mining approaches have been employed 10 formulate
`a semiquantitative means of predicting the effect of primary s1ructure on rate of
`deamidation. Capasso (58) proposed the extrnthermodynamic relationship shown
`in Equation I :
`
`(I)
`l-lerc k1 is the observed rnte c:onsmn1 for denmidntion, Xr i.� the ave.rage contribu­
`tion of the specific umino acid 1hn1 precede� A.�n. Y11 i� the nverage cnntribution
`due to the amino acid that follows A,n. and z,.._... is the v:iluc when both the preced­
`ing und following amino ncids nre glycine.. Ovc.r 60 pc.prides were included in the
`darubase. As expected. rhc grcate�t influence on 1hc de,11nidn1ion rate in peptides
`wa� found to oris:e frorn 1he idcn1i1y of the following ninino acid. Soinc of the
`values for Y1, ore listed in Tobie I. A., suggested previnusly. relative 1n 1he effect
`of glycine. bulky hydrophobic amino acids s:uch as vnnne. lcucine, and isolcucinc.
`
`Table 1 Rate Constants Reported for the Rcactiona of
`
`
`
`
`OW with the Slde Chains of Selected Amino Adds (IOI)
`
`5 >< IO'
`
`Amino acid k (Umole-s)>
`4.7 X 1016
`CyslCine
`1.3 >< IO'◊
`Tyrosint
`1.3 >< IO'°
`fryptopban
`Histidine
`Methionine 8.3x 10•
`Phenylalanine 6.5x 10•
`3.5 x JO'
`Arginine
`Cystine
`2.1 X 10"
`3.2 )c 10•
`7.7 X !01
`
`Serine
`Alanine
`
`•Most vnlues dcttonnined vi11 radiolysis.
`
`
`
`
`'The pH values of many of these studies have not been listed.
`
`Bausch Health Ireland Exhibit 2010, Page 12 of 38
`Mylan v. Bausch Health Ireland - IPR2022-01105
`
`

`

`,...---
`
`Chemical Considerations in Protein and Peptide Stability
`
`1 7
`
`appear t o show t h e slowest deamidation rate, w h i l e the smaller, more polar histi­
`dine and serine show a rate closer to that of glycine. There do appear to be some
`d iscrepancies between these resu l ts and those mentioned earliec ( 1 2, 1 6.57), in
`particular with respect to the experimentally observed effect of histidine. Clearly,
`different databases may give different result . At best, Equation I may be viewed
`as a first approximation for estimating deamidation rates in fonnulation studies.
`Robinson el al. (59-6 1 ) have taken a different approach to mining by
`including means to account for the three-dimensional structure of the side-chains
`and by avoiding the use of data gathered in the presence of the known catalyst,
`phosphate buffer. A method has been proposed to estimate the dcamidation reac­
`tion half-life al 37 °C and pH ; 7.4 based on the primary sequence (61 ). The
`extent to which this method may accurately predict the dcamidation rate of pep­
`tides in pharmaceutical systems has not yet been rigorously tested experime.n­
`tally, but if proven valid, it would supply a rather useful tool in guiding early
`formulation studies.
`
`Secondary and Tertiary Struct u re
`
`X-ray or nuclear magnetic resonance (NMR) data can provide a detailed map of
`the three-dimensional structure of the protein or peptide. The role of secondary
`and tertiary structures in intramolecular dcamidation of proteins has been dis­
`cussed by Chazin and Kossiakoff (62), It is beyond the scope of this work to
`present n comprehensive review of the details of deamidation reactions in spe­
`cific proteins. Excellent reviews of a variety of specific proteins exist (6). For the
`most part, detailed mechanisms relating the secondary and tertiary structures of
`proteins to enhancement of rates of deamidation are not yet available.
`Clear differences in the deamidation rates of some proteins a.re evident when
`native and denatured states are compared ( 1 3.63). Denaturation is though no enhance
`main-chain ftexibi1ity and water accessibility (62), Sufficienl conformational Hex­
`-l 20°C
`ibility is required for the Asn peptide to assume the dihedral angles of <I>
`and lf1 = + l 20°C necessary for succinimide formation. ln as much as such angles
`tend to be energetically unfavorable (64) in native proteins, it may be expected that
`Asn residues in the midst of rigid secondary structures, such as helices, may be
`resistant to deamidation. Other reactions, such as cross-linking might also give rise
`to rigid regions of the protein and enhanced resista

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket